OSTX - OS Therapies Inc
1.57
0.060 3.822%
Share volume: 543,990
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$1.51
0.06
0.04%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 11-15-2024 | 05-15-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 2.437 M | 4.999 M | 6.880 M | |
| Selling general and admin | 1.227 M | 3.690 M | 3.124 M | |
| Research and development | 1.210 M | 1.309 M | 3.755 M | |
| Total expenses | 2.437 M | 4.999 M | 6.880 M | |
| 105.12% | 37.61% | |||
| Operating income | -2.437 M | -4.999 M | -6.880 M | |
| Ebit | -2.437 M | -3.877 M | -6.880 M | |
| Pretax income | -2.875 M | -3.877 M | -6.880 M | |
| 34.84% | 77.45% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -2.875 M | -3.877 M | -6.880 M | |
| -34.84% | -77.45% |